论文部分内容阅读
按照 WHO全球哮喘防治会议提出的治疗儿童轻度哮喘方案 ,倍氯米松的推荐剂量为 2 0 0~ 5 0 0μg/ d具有较佳的临床效果 ,且无明显全身副作用。我国哮喘儿童持续吸入≥40 0 μg/ d的倍氯米松 3个月可引起不同程度的下丘脑 -垂体 -肾上腺轴功能的抑制 [1 ] 。为避免激素的副作用
According to the WHO global asthma prevention and treatment conference proposed treatment of mild asthma in children program, the recommended dose of beclometasone 200 ~ 500μg / d has a better clinical effect, and no obvious systemic side effects. Continuous inhalation of ≥40 0 μg / d of beclomethasone in children with asthma in our country for 3 months can cause different degrees of hypothalamic-pituitary-adrenal axis inhibition [1]. To avoid hormonal side effects